Calmark's LDH test for assessment of COVID-19 disease severity is estimated to be ready for launch in Q1 2021
Calmark Sweden AB announces today that the product development of an LDH test for assessment (triage) of COVID-19 is proceeding according to plan; the test is now projected to obtain CE conformity marking in Q1 2021. The project has now successfully completed the chemical impregnation in Calmark's recently installed BioDot machine, which will be used in the production line.CE conformity marking and the development of medical technology products follows a seven-step process, where the first three steps involve identification of requirements specification and development to cover them. The